文献速递肝病消化道肿瘤与早癌

USP22通过HIF1α/USP22正反馈环路在TP53失活时促进缺氧诱导的肝细胞癌干性

USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
PubMed 文献 · Gut · 2019-11-27

该研究旨在阐明泛素特异性蛋白酶22(USP22)与缺氧诱导因子-1α(HIF1α)的相互调控机制及其在缺氧条件下促进肝细胞癌(HCC)细胞干性的作用。研究发现USP22通过去泛素化稳定HIF1α促进缺氧诱导的HCC干性和糖酵解;在TP53突变HCC细胞中,USP22和HIF1α形成正反馈环路促进干性,且TP53功能缺失突变伴USP22和/或HIF1α高表达的患者预后更差。靶向USP22的脂质多聚复合物在HCC小鼠中显示高肿瘤抑制和高索拉非尼敏感性。

要点

  • USP22通过去泛素化稳定HIF1α促进缺氧诱导的HCC干性和糖酵解。
  • TP53突变HCC中USP22和HIF1α形成正反馈环路促进干性。
  • 靶向USP22的脂质多聚复合物在HCC小鼠中抑制肿瘤并增敏索拉非尼。

核心结论

  • USP22通过TP53失活时的HIF1α/USP22正反馈环路促进缺氧诱导的HCC干性。
  • USP22是HCC治疗的有前景靶点。

研究设计与样本

  • 研究采用细胞计数、迁移、自我更新能力、化疗耐药和干性基因表达检测HCC细胞干性。
  • 使用免疫沉淀、泛素化实验和染色质免疫沉淀实验阐明USP22和HIF1α相互调控机制。
  • 利用HCC患者样本和癌症基因组图谱(TCGA)数据展示临床意义。
  • 在荷HCC小鼠中进行体内靶向USP22实验。

主要发现

  • USP22通过去泛素化稳定HIF1α促进缺氧诱导的HCC干性和糖酵解。
  • 缺氧条件下HIF1α可转录上调USP22和TP53。
  • TP53野生型HCC细胞中,HIF1α诱导的TP53抑制HIF1α诱导的USP22上调。
  • TP53突变HCC细胞中,USP22和HIF1α形成正反馈环路促进HCC干性。
  • TP53功能缺失突变且USP22和/或HIF1α高表达的HCC患者预后更差。

关键数值与推荐

  • TP53功能缺失突变且USP22和/或HIF1α高表达的HCC患者倾向于更差预后。

临床怎么用

  • USP22可作为HCC治疗的潜在靶点。
  • 靶向USP22的脂质多聚复合物在HCC小鼠中显示高肿瘤抑制和高索拉非尼敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to elucidate the mutual regulation mechanism of ubiquitin-specific protease 22 (USP22) and hypoxia inducible factor-1α (HIF1α), and the mechanism they promote the stemness of hepatocellular carcinoma (HCC) cells under hypoxic conditions. DESIGN: Cell counting, migration, self-renewal ability, chemoresistance and expression of stemness genes were established to detect the stemness of HCC cells. Immunoprecipitation, ubiquitination assay and chromatin immunoprecipitation assay were used to elucidate the mutual regulation mechanism of USP22 and HIF1α. HCC patient samples and The Cancer Genome Atlas data were used to demonstrate the clinical significance. In vivo USP22-targeting experiment was performed in mice bearing HCC. RESULTS: USP22 promotes hypoxia-induced HCC stemness and glycolysis by deubiquitinating and stabilising HIF1α. As direct target genes of HIF1α, USP22 and TP53 can be transcriptionally upregulated by HIF1α under hypoxic conditions. In TP53 wild-type HCC cells, HIF1α induced TP53-mediated inhibition of HIF1α-induced USP22 upregulation. In TP53-mutant HCC cells, USP22 and HIF1α formed a positive feedback loop and promote the stemness of HCC. HCC patients with a loss-of-function mutation at TP53 and high USP22 and/or HIF1α expression tend to have a worse prognosis. The USP22-targeting lipopolyplexes caused high tumour inhibition and high sorafenib sensitivity in mice bearing HCC. CONCLUSION: USP22 promotes hypoxia-induced HCC stemness by a HIF1α/USP22 positive feedback loop on TP53 inactivation. USP22 is a promising target for the HCC therapy.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Ling S, Shan Q, Zhan Q, et al. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation. Gut. 2019. PMID: 31776228. doi:10.1136/gutjnl-2019-319616

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。